BioFlyte Appoints Bill Rule as Vice President of Manufacturing

Rule brings over 20 years of international supply chain and manufacturing expertise to build out BioFlyte’s manufacturing operations and meet growing demand for biothreat surveillance solutions

ALBUQUERQUE, N.M.–(BUSINESS WIRE)–BioFlyte, a bioaerosol surveillance firm with a disruptive new class of fieldable biological threat collection, detection, and identification solutions, today announced the appointment of Bill Rule as Vice President of Manufacturing. In this role on the BioFlyte leadership team, Rule will oversee the development of a dedicated manufacturing function and manage a robust supply chain model as the company scales its commercialization efforts.


Rule has a proven track record of helping startups and small companies scale by implementing successful supply chain and manufacturing processes. Most recently, he served as the Director of Manufacturing and Supply Chain for Everactive, an IoT platform company. For the last several years, Rule has also managed his own supply chain and manufacturing engineering consultancy where he has assisted small to mid-sized companies with projects ranging from international factory stand up and quality control, to new product introduction and prototype production planning.

Rule laid the groundwork for his successful career during his time at Aruba Networks, now a Hewlett Packard Enterprise company, where he worked his way up to the roles of Senior Director, Manufacturing Engineering and, later, Vice President of Global Supply Chain. He led the team that was responsible for new product introduction, global contract manufacturing qualification, supply chain qualification, and more.

“BioFlyte has the opportunity to capitalize on the growing interest in and demand for bioaerosol surveillance technologies with a global manufacturing and supply chain operation,” said Todd Sickles, CEO of BioFlyte. “Bill has the right set of skills and experience that helped scale global supply chains at Aruba Networks and will now help ensure the supply side of our business can sustainably support this growing market demand. We are excited to welcome him to the team at this critical time in our evolution.”

“BioFlyte’s technology has the potential to transform the way we monitor for and respond to the ever-evolving realm of biothreats,” said Bill Rule. “I am thrilled to be joining such a talented and industry savvy team and look forward to using my expertise to help the company scale the use of this disruptive technology.”

To learn more about BioFlyte, please visit https://bioflyte.com.

About BioFlyte

BioFlyte is a bioaerosol surveillance company that is commercializing a revolutionary new class of fieldable biological contamination sampling, detection, and identification solutions. The firm’s current application focus is critical infrastructure protection and pandemic response. For more information about BioFlyte and its products, please visit: https://bioflyte.com.

Contacts

Media
Kalyn Kolek for BioFlyte – [email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.